Table 1.
Sociodemographic and clinical characteristics of PTSD patients and controls
| Variables |
PTSD |
Controls |
p |
|---|---|---|---|
| (n = 35) | (n = 25) | ||
| Agea (y) |
32.6 ± 9.1 |
29.1 ± 9.7 |
.01 |
| Sex (f/m) |
16/19 |
17/8 |
.09 |
| Region of Origin (%) |
|
|
.06 |
| Africa |
20.0% |
8.0% |
|
| Balkan |
17.2% |
48.0% |
|
| Middle East |
62.8% |
44.0% |
|
| Smokers (%) |
37.1% |
16.0% |
.07 |
| Psychotropic medication (%) |
37.1% |
0% |
<.0005 |
| Hypnotics |
14.3% |
0% |
|
| Anxiolytics |
11.4% |
0% |
|
| Antidepressives |
25.7% |
0% |
|
| Neuroleptics |
8.6% |
0% |
|
| Contraceptives (%) |
2.8% |
16.0% |
.10 |
| Comorbid depression (%) |
77.1% |
0% |
<.0005 |
| Number of traumatic event typesa |
|
|
|
| War or torture events |
10.8 ± 5.4 |
2.3 ± 5.0 |
<.0005 |
| CAPS events |
6.9 ± 2.1 |
3.4 ± 2.0 |
<.0005 |
| CAPS Scorea |
80.0 ± 17.5 |
5.4 ± 11.2 |
<.0005 |
| HAMD Scorea |
26.1 ± 8.2 |
4.1 ± 5.6 |
<.0005 |
| SOMS Scorea | 28.7 ± 12.4 | 5.5 ± 8.5 | <.0005 |
aData are presented as mean ± SD.
*For pair-wise group comparisons of continuous variables, we performed t-tests, differences of categorical variables were evaluated by applying χ2 tests for independence. (Y) = years; (f) = female; (m) = male; CAPS, Clinician Administered PTSD Scale; HAM-D, Hamilton Depression Rating Scale; SOMS-7, Screening for Somatoform Symptoms-7.